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Attention Deficit/Hyperactivity Disorder (AD/HD) is a neuropsychological
disorder that affects an estimated 2-5% of adults and 3-7% of children in the U.S.
Many adults remain undiagnosed until their college-age years. There are several
academic, personal and financial benefits to receiving an AD/HD diagnosis in college
and some adults seeking the diagnosis exaggerate feign, or malingering AD/HD
symptoms. To enhance clinical assessment, this study evaluated the susceptibility of
eight instruments (self-report rating scales, neuropsychological measures, symptom
validity measures, and psychiatric feigning inventories) to malingered AD/HD using
a 2 (malinger vs. respond honestly) x 2 (AD/HD enhanced knowledge or non-AD/HD
enhanced knowledge) analogue simulation research design.
Self report measures are the most common form of AD/HD screening tools
used by clinicians in addition to a clinical interview. This study assessed knowledge
of AD/HD using the Adult Knowledge of Attention Deficit Disorder Scale
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(AK.ADDS; Watkins & Reilley, 2009), childhood AD/HD symptoms, using the
Childhood Symptom Scale- Self Report (CSS-SF; Barkley & Murphy, 1998), and
current AD/HD symptoms, using the Current Symptoms Scales (CSS; Barkley &
Murphy, I 998). It was predicted and found that reading about symptom criteria
enhanced participants' knowledge of AD/HD, but that knowledge of AD/HD wasn't
required for .successful malingering of childhood and current AD/HD symptoms on
the CSS-SF and CSS, respectively.
Neuropsychological instruments are also commonly included in AD/HD
evaluation as specific aspects executive functioning are thought to underlie behavioral
deficits in AD/HD (Barkley, 2008). However, the impact of malingered AD/HD on
such measures is often not known. The Behavior Rating Inventory of Executive
Functioning- Adult Version Form (BRIEF-A; Roth, Isquith, & Gioia, 2005) is a selfreported measure of executive dysfunction. Partial support was found for hypotheses
involving the BRIEF-A as malingering groups scored significantly higher the nonmalingering groups, but not higher than normative data from an unmedicated clinical
sample of AD/HD adults. The Delis-Kaplin Executive Functioning System Trail
Making Task (D-KEFS TMT; Delis, Kaplan, Kramer, 2001a) is a paper-and-pencil
measure of different aspects of executive functioning (e.g., visual scanning,
sequencing, and motor speed). Partial support was found for hypotheses involving the
D-KEFS as malingering groups scored significantly higher than non-malingerers
except for the predicted letter-number switching task.
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The utility of symptom validity measures including the WAIS-IV Digit Span
Task and Reliable Digit Span Task (RDS) and the Test of Malingered Memory
(TOMM) were evaluated. Partial support was found for the Digit Span task as
malingerers scores significantly lower than non-malingerers on the total Digit Span
score and the new Digit Sequencing Task. Full support was found for hypotheses
involving the TOMM as malingerers scored significantly poorer than non-malingerers
on all TOMM trials.
Individuals asked to malinger AD/HD symptoms often display deficits on
measures of executive functions and portray psychiatric symptoms in excess to those
reported by normal controls and those with AD/HD (Booksh, 2005; Harp, Jasinski,
Shandera-Oshsner, Mason, Berry, 2011; Harrison et al, 2007). Using the Structured
Inventory for Malingered Symptomatology (SIMS; Widows & Smith, 2005) the
current study predicted and found that participants asked to malinger AD/HD
reported an broad number of erroneous psychiatric symptoms.
The present study improves on the existing literature in the area of AD/HD
assessment and suggests a carefully selected battery of instruments, including
measures to aid in detection of malingering, is needed when assessing adults for
AD/HD.
Accepted by:
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Detection of Malingered AD/HD in College Students
Attention Deficit/Hyperactivity Disorder (AD/HD) is a neuropsychological
disorder with symptoms and impairment thought to emerge first in childhood
(Barnett, Maruff, & Vance, 2009). Approximately 50-65% of children diagnosed with
AD/HD continue to experience significant clinical symptoms with impairment in
psychosocial and cognitive functioning in adulthood (Barkley, 201 0; Barkley,
Fischer, Smallish & Fletcher, 2002; Booksh, 2005; Manos, 201 0; McGough &
Barkley, 2004). Thus, it is estimated that 3-7% of children and 4-6% of adults in the
U.S. have AD/HD (Able, Johnston, Adler, & Swindle, 2007; Austin, Reiss, &
Burgdorf, 2007; Kessler, Adler, Barkley, Conners, Demler, Faraone, Greenhill,
Howes, Secnik, Spencer, Ustun, Walters, & Zaslavsky, 2006; Pastor & Reuben,
2008).
Attention Deficit /Hyperactivity Disorder is a complex disorder with differing
sets of inattentive and/or hyperactive-impulsive symptoms common across
individuals (Manos, 201 0; Yan et al., 20 I 0). The variability in the presentation of
AD/HD is treated by classifying the symptoms into one of three subtypes of AD/HD
in the current"edition of the Diagnostic and Statistical Manual of Mental Disorders,
Fourth Edition- Text Revision (APA, 2000): AD/HD Predominantly Inattentive type
(AD/HD-PI), AD/HD Predominantly Hyperactive-Impulsive Type (AD/HD-PH), and
AD/HD Combined Hyperactive/Inattentive Type (AD/HD-C). To be diagnosed with
AD/HD, the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV TR;
APA, 2000) requires a sufficient number of AD/HD symptoms (minimum of 6

5

inattentive and/or 6 hyperactive symptoms) be developmentally inappropriate and
present for at least six months (DSM Criteria A). Some AD/HD symptoms with
impairment must have been present before age seven (DSM Criteria B). The AD/HD
symptoms must be impairing in at least two areas (or settings) of the individual's life
(DSM Criteria C) with clinical impairment to a significant degree in social, academic,
or occupational functioning (DSM Criteria D). Finally, the mental health practitioner
needs to demonstrate that the AD/HD symptoms are not better accounted for by
another disorder (DSM Criteria E).
Accurate detection of AD/HD in adults is important for initiating treatment to
lessen the severity of inattentive, and/or hyperactive-impulsive symptoms, and
accompanying interpersonal, occupational, academic or intrapersonal difficulties
(Marchetta, Hurks, Krabbendam, & Jolles, 2008). Adults with AD/HD are at risk for
relationship problems such as decreased satisfaction in their marriages, increased
stress related to parenting difficulties, and higher rates of divorce and extra-marital
affairs, (Goodman, 2007; Ramsay, 2010). Problems with AD/HD in the work place
are common and often involve adults being late to work or meetings, being
disorganized, or not completing work tasks on time (Barkley, 20 IO; Booksh, 2005).
Difficulties with multitasking, managing large workloads, and/or getting along with
coworkers can also lead adults with AD/HD to underperform at work, thus leading to
increased risk for being placed on suspension or problems maintaining long-term
employment (Barkley, 2010; Halmoy, Fasmer, Gillberg, & Haavik, 2009).
Academically, individuals with AD/HD are at risk for underperforming compared to
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their non-AD/HD counterparts in many academic areas and may need special services
or tutoring (Barkley, 2010; Booksh, 2005; Corkum, McGonnell, & Schachar, 2010).
Many adults with AD/HD suffer personal difficulties such as impulsive or
risky decision making leading to poor money management, or legal difficulties due to
excessive speeding or increased rates of automobile accidents (Knouse, Bagwell,
Barkley, & Murphy, 2005). Barkley (2010) reports adults with AD/HD have higher
rates of medical conditions such as heart disease (2.4% higher), body mass index
(11 .4% higher), total/HDL cholesterol (20% higher), are more likely to have sleep
problems (2.5% higher), and to use nonmedical drugs (2.2% higher). The occurrence
of these medical conditions in individuals with AD/HD has been attributed to
impulsive decision making and difficulty considering the long-term consequences of
their health choices involving preventative and regular self-care (Barkley, 2010).
With respect to mental health, Cumyn, French, and Hechtman (2009) found adults
with AD/HD display higher rates of psycliological disorders on both Axis I (46.9%
vs. 27.31 %) and Axis II (50.7% vs. 38.2%) of the DSM-IV-TR (APA, 2000) as
compared to the general population. As corroborated and expanded by other research,
AD/HD appears to have the highest co-morbidity rates with anxiety disorders (4750% comorbidity; Biederman, 1998; Kessler et al., 2006), mood disorders (37-38%
- comorbidity; Downey, Stetson, Fonerleau, & Giordani, 1997; Kessler et al., 2006),
substance abuse disorders (15-46% comorbidity; Biederman, 1998; 15% comorbidity;
Kessler et al., 2006), and antisocial personality disorder or antisocial behaviors (1-4
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times more likely; Barkley, Murphy, & Fischer, 2008; Biederman, 1998; Kessler et
al., 2006).
Despite the physical and mental health risks associated with AD/HD as well
as the accompanying occupational, academic, and/or interpersonal problems, a
majority of adults with AD/HD remain undiagnosed. Klassen, Katzman, & Chokka
(2010) suggest an adult suffering from AD/HD may never be diagnosed simply
because he/she may never seek services or may be seen by a practitioner who is less
familiar with AD/HD in adults. Adler & Cohen (2004) and Manos (20 I 0) point out
that many mental health providers may miss an AD/HD diagnosis because AD/HD
has long been viewed as a childhood disorder, is currently assessed using diagnostic
criteria that were developed on children, and some diagnostic symptoms appear to
change from childhood to adulthood. Others (Fox, 2008; Reilley, 2005; Searight,
Burke, & Rottneck, 2000) point out that AD/HD symptoms appear to overlap with a
variety of medical and psychological problems, and thus AD/HD often goes
undetected or is misdiagnosed. For example, the symptoms of inattention and
distractibility are also often seen in individuals that have a medical condition such as
hypothyroidism or chronic pain, or, those with learning, mood, or anxiety disorders
(Fox, 2008; Reilley, 2005; Searight, Burke, & Rottneck, 2000). Individuals that have
sustained head injuries, those who abuse substances, or suffer from bipolar disorder,
antisocial or borderline personality disorder display symptoms of impulsivity and
restlessness (Fox, 2008; Klassen, Katzman, Chokka, 20 IO; Searight et al., 2000). As
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such, the mental health professional faces a range of diagnostic challenges in
assessing adults for AD/HD.
Assessment of AD/HD by mental health professionals

Due to differences in diagnostic approaches used by mental health
professionals, there is currently no gold standard assessment in the field of
psychology for reliably determining a diagnosis of AD/HD (Manos, 2010; McGough

& Barkley, 2004). Medical professionals utilize a variety of techniques to assess
AD/HD in adults including clinical interviews, medical examinations, self-and
collateral screening measures and/or external evaluations from other mental health
professionals (Booksh, 2005; McGough & Barkley, 2004; Quinn, 2003; Solloman et
al, 2010; Wasserstein, 2005). Similar to physical health evaluations, many adults that
come in for assessment are the sole informant of their behavior. Thus, many medical
professionals frequently make decisions about an AD/HD diagnosis on self-reported
history and interview information provided by the client, and, when possible, data
from AD/HD screening measures administered during the visit. Adler, Shaw, S_itt,
Maya, and Morrill (2009) report that 75% of 400 primary care physicians surveyed
believed current AD/HD screening instruments had poor to fair accuracy. As a result,
85% of the physicians surveyed indicated that until a more accurate screener was
developed they-would remain hesitant to take a more active role in diagnosing and
treating adult AD/HD (Adler et al., 2010).
Psychologists often incorporate neuropsychological measures with data
obtained from clinical interviews and self-and-collateral ratings of AD/HD behaviors
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in their evaluations of adults for AD/HD (Manos, 20 IO; Suhr, Hammers, DobbinsBuckland, Zimak, Hughes, 2008). Neuropsychological instruments are attractive for
clinicians to include for two reasons: (I) to selectively assess aspects of executive
functioning which are thought to underlie behavioral deficits in AD/HD (Lovejoy,
Ball, Keats, Stutts, Spain, Janda, & Janusz, 1999; Wasserstein, 2005), and (2) to
evaluate whether the examinee's effort on cognitive and behavioral measures in the
assessment might be considered suspect, thus raising the possibility of malingered,
feigned, or exaggerated AD/HD symptoms (Booksh, 2005; Quinn, 2003; Suhr et al.,
2008).With regard to the former, executive functions are fundamental human selfdirected mental processes mediated chiefly by the prefrontal lobes of the brain
(Barkley, 1997, 2001). Executive functions aid individuals in self-control for
performing larger, real world behaviors such as paying attention, remembering
details, or managing time (Lezak, 2004; Wasserstein, 2005). Disagreement about the
core components of executive functioning exists among researchers, but typically
actions for shifting sets, inhibition of behavior, sequencing and planning for events,
, engaging in selective and sustained attention, and use of working memory are
included (Lezak, 2004; Lovejoy et al., 1999; Martinussen, Hayden, Hogg-Johnson, &
Tannock, 2005; Nigg, 2005). Barkley et al. (2008) argue that AD/HD chiefly disrupts
inhibition leading to problems in multiple executive components. Available metaanalyses of both child and adult AD/HD executive functioning studies conducted to
date (Aguiar, Eubig, & Schantz, 2010; Castellanos, Sonuga-Barke, Milham, &
Tannock, 2006; Dickstein, Bannon, Castellanos & Milham, 2006; Freidman &
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Miyake, 2004; Harvey, Epstein, & Curry, 2004; Lansbergen, Kenemand, & van
Engeland, 2007; Schoechlin & Engel, 2005; Walshaw, Alloy, & Sabb, 2010; Willcutt,
Doyle, Nigg, Faraone, & Pennington, 2005; Woods, Lovejoy, & Ball, 2002) provide
partial to full support for this view with moderate overall effect sizes observed for
executive components involving response inhibition, planning, sustained attention,
and working memory.
As noted previously, neuropsychological tests are also becoming increasingly
used as part of an assessment battery to evaluate a client's effort, especially when
there are significant incentives to malinger or underperform (Inman & Berry, 2002;
Quinn, 2003; Young & Gross, 2011). Malingering is defined in the DSM-IV-TR as
"intentional production of false or grossly exaggerated physical or psychological
symptoms, motivated by external incentives" (APA, 2000, p. 739). Incentives that
may promote malingering or feigning of AD/HD, and, subsequent compromised
performance on neuropsychological tests are plentiful (c.f., Young & Gross, 2011).
For adults in college, successful malingering can lead to unwarranted academic
accommodations such as extra time on exams and assignments, ability to take tests in
a distraction free or a quiet room away from others, alternative or reduced homework
loads, and ancillary resources such as recorded lectures and/or books on tape
· · (Sollomon, Ranseen, & Berry, 2010; Young & Grossman, 2011). Adults in a noncollege work environment can request occupational accommodations which if granted
can lead to undue financial costs for the employer (Alfano & Boone, 2007; Sullivan,
May, & Galbally, 2007). Most pharmacological treatments for AD/HD involve
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stimulant medication that can also provide benefits for adults that do not have the
disorder (Advokat, Guidry, & Martino, 2008; Harrison, 2006; Snider, Busch, &
Arrowood, 2003 ). In fact, the use of stimulant medications has increased on
university campuses from the undergraduate to graduate level (Advokat, Guidry, &
Martino, 2008; Harrison, Edwards, Parker, 2007). College students without AD/HD
can use stimulant medications recreationally, or as study aids, or can sell them
(Advokat, Guidry, & Martino, 2008; Young & Gross, 201 I). However, stimulant
medication abuse is not just specific to college adults given as many as 12% of state
prisoners used stimulant medications illicitly a month prior to their offense
(Applebaum, 2008). Medications used to treat AD/HD in adults such as Ritalin and
Adderall are also found in prisons where these medications can be sold and abused by
inmates. In fact, financial gain or fulfillment of substance of choice can be the basis
for prisoners malingering to obtain these medications (Applebaum, 2008; Bums,
2009; Mumola & Karberg, 2004). Finally, adults claiming to have ADHD can also
stand to gain Social Security Disability benefits. In addition, successful malingers can
avoid military service or deployment (Friedman, Blaschke, Klam, & Stein, 2010).
This may be incentive for some adults in the military to either malinger or
underreport AD/HD symptoms.

- Assessment of Malingering of AD/HD
Self-report instruments such as AD/HD rating scales are the most widely used
AD/HD evaluation instruments secondary to a clinical interview (Fischer & Watkins,
2008). Currently, most of the popularly used AD/HD self-report rating scales are
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based on AD/HD symptoms that share some relation to the current DSM typology for
AD/HD, but often differ in the time frame for the symptom reporting (Fisher &
Watkins, 2008). For instance, the ADHD Behavior Checklist (Murphy & Barkley,
1996a) was developed based on the DSM criteria for AD/HD and uses a 6-month
time frame for symptom reporting whereas the Conners Adult AD/HD Rating Scale
uses a "recent" time frame, albeit, without a concrete duration of months. Although
AD/HD rating scales may differ in their fidelity to the DSM-IV-TR criteria or time
frame for symptom reporting, most, if not all of the current AD/HD self-report
measures for adults (Attention Deficit Scale for Adults; Current Symptoms Scales,
CSS; Barkley & Murphy, 1998; Childhood Symptom Scale- Self Report, CSS-SRF;
Barkley & Murphy, 1998; Wender-Utah ADHD scale; Ward et al., 1993) fail to
reliably differentiate AD/HD individuals from those asked to malinger AD/HD in
research studies (Booksh, 2005; Jachimowicz & Geiselman, 2004; Quinn, 2003;
Soll om on et al., 2010). One common reason for this finding is that most AD/HD
rating scales used for adults lack validity scales, thus rendering an instrument
vulnerable to exaggeration of symptoms, feigning, or malingering (Young & Gross,
2011).
Because self-reports of AD/HD symptoms are often vulnerable to
malingering, the current view in neuropsychological testing is to include instruments
that can evaluate the suspected effort of the individual (Berry & Granacher, 2009).
Self-reports of executive dysfunction such as the Behavior Rating Inventory of
Executive Functioning-Adult (BRIEF-A; Roth, Isquith, & Gioia, 2005) version are
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increasingly being used in AD/HD evaluation and typically involve ratings of
different components of executive functions using a neuropsychological theory or
model of executive dysfunction. Unfortunately, there is a paucity of research on
malingering and neuropsychological rating scales, especially in the area of
malingered Attention Deficit/Hyperactivity Disorder. There appears to be a larger
general research base, however, regarding use of behavioral neuropsychological
measures in studies of adults with AD/HD, including those asked to malinger
AD/HD. These types of measures include the Test of Malingered Memory (TOMM;
Tombaugh, 1996) and the Wechsler Digit Span Test (Pearson, 2009) which are
discussed in subsequent sections. In addition, research has begun to examine the
impact of malingered AD/HD on forensic measures, and symptom validity measures.
A more thorough review of the current findings for behavioral neuropsychological
measures, psychiatric feigning measures, and symptom validity measures is provided
herein to provide a context for hypothesis testing in the current study using subsets of
these measures.
Neuropsychological Measures

Attention Deficit/Hyperactivity Disorder is a neuropsychological disorder
with executive functioning problems believed to underlie overt behavioral and
cognitive problems. As such, ueuropsychological measures that assess adults' ability
to inhibit their behavior, to sequence and plan for events, to shift sets, to engage in
selective and sustained attention, and to adequately deploy working memory are of
interest. A meta-analysis conducted by Schoechlin & Engel (2005) found large effect
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sizes for working memory and sustained attention when adults with AD/HD were
compared to non-AD/HD controls. Prior research from other authors have noted the
significant deficits in multiple executive functions (i.e., attention, memory, and
inhibition) demonstrated by individuals with AD/HD (Harvey, Epstein, & Curry,
2004). A meta-analysis by Frazier, Demaree, and Youngstrom (2004) did not find the
same large effect sizes reported by Schoechlin et al. (2005). The authors hypothesized
that executive functioning deficits may affect estimates of the individual's overall
intellectual abilities, thus resulting in lower effect sizes between groups. For other
executive functions, meta-analytic reviews have found medium effect sizes for verbal
fluency, inhibition, and set shifting (Boonstra, Ooster!aan, Sergant, & Buitelaar,
2005).
Variants of the Stroop Test (Stroop, 1935) have been used to measure
response inhibition and interference in individuals with AD/HD compared to controls
without AD/HD. During the Stroop task, the individual is given a card in which color
names (e.g., Red, Blue, Green, Black, etc) are listed in different colors (e.g., the word
Blue is printed in Red ink). The examiner typically asks the examinee to read
achromatic color names, and/or to identify color-congruent colored names as a
priming task and then to respond to a color-incongruent word naming task to assess
their response inhibition and interference. In recent research on malingered AD/HD,
researchers have found that this task is insensitive to AD/HD symptoms and that
often times, those with or without the disorder can score within the normal range
(Sollman et al., 2010). Nevertheless, Solloman et al. (2010) demonstrated that this
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task did have some ability to differentiate between malingering AD/HD participants
and true AD/HD participants because those malingering AD/HD had significantly
more scores in the borderline to impaired range when compare to those diagnosed
with AD/HD.
Another popular neuropsychological instrument used in the evaluation of
AD/HD are continuous performance measures such as Conners Continuous
Performance Test (Conners, 2000), Test of Variable Attention (TOVA; Greenberg &
Waldman, 1993), and the Integrated Visual and Auditory Continuous Performance
Test (IV A-CPT; Sanford & Turner, 1995). These tasks gauge the selective and
sustained attention of an individual as well as response inhibition. The individual is
asked to respond on a computer to an infrequently presented stimulus (e.g., a target
letter). Performance is assessed by correct responses, incorrect responses or errors of
commission, and omission errors where the individual failed to respond to a target.
Studies have shown that individuals with AD/HD do perform more poorly than
normal controls (Booksh, 2005; Epstein, Conners, Sitarenios, & Erhardt, 1998;
Quinn, 2003). However, those asked to malinger AD/HD in research have also
performed more poorly than both normal controls and those with AD/HD, so the
conclusions of the assessment alone is not always conclusive whether the person is
malingering or has AD/HD (Wilding, 2005).
The Trail Making Test (TMT) Parts A & B, originally developed by the
United States Army (1944), measures simple and complex planning and sequencing
and alternating attention. Meta-analyses have shown a moderate effect for completion
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time differences for Part A and Part B between AD/HD and control participants
(Delis, Kaplan, Kramer, 200 I a). On Trails A, individuals are asked to draw a line
connecting a series of circles with a number displayed inside of it, similar to a
connect-the-dots puzzle. On Trails B, the circles contain both numbers and letters and
the individual is to connect the circles in an alternating pattern of numbers and letters
(e.g., 1-A-2-B-3-C .... etc). In one malingering study, there was evidence that the Trail
Making Test (TMT) could differentiate between malingered and true AD/HD because
malingerers performed significantly worse than the individuals with true AD/HD on
the Trails A of the TMT (Booksh, 2005). Newer variations on the TMT, e.g., the
Delis-Kaplan Executive Functioning System Trail Making Task (D-KEFS TMT;
Delis, Kaplan, Kramer, 2001a), have not yet been used in adult AD/HD malingering
studies, although there are good reasons to consider the D-KEFS in future
neuropsychological and malingering research.
Benefits of the D-KEFS TMT, in comparison to the original TMT, include the
ability to isolate specific performance skills (Delis, Kaplan, Kramer, 200 I a). Unlike
the traditional TMT which measures a group of skills (e.g., visual scanning and
number sequencing in the TMT A trial), the D-KEFS separates out these skills into
separate tasks in order to determine which specific deficits are present for the
-individual. The D-KEFS includes five tasks or conditions that measure: I) Visual
Scanning, 2) Number Sequencing, 3) Letter Sequencing, 4) Number-Letter
Switching, and 5) Motor Speed. This allows the examiner to then make conclusions
regarding whether difficulties on the task are related to a "higher-level deficit in
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cognitive flexibility and/or to one or more fundamental component skills tapped by
the task" (Delis, Kaplan, Kramer, 2001a, p.4). Wodka, Loftis, Mostofsky, Prahme,
Gidley Larson, Denckla, and Mahone (2008) did not find support for the D-KEFS
trail making tasks to differentiate children with and without AD/HD_. However, Peden
(2010) did find performance on the D-KEFS trail making task involving letternumber switching was significantly poorer in children with AD/HD relative to nonAD/HD controls. For the present study, the D-KEFS is of interest for isolating which
components measured by the test are prone to malingered AD/HD in an adult sample.
Many AD/HD studies involving neuropsychological measures have included
subtests of the Wechsler Adult Intelligence Scale-III (WAIS-III; Wechsler, 1997).
The WAIS-III is an intellectual measure that includes a variety of tasks which
measure a variety of abilities and functions of the individuals. Working memory and
sequential processing which are purported deficits in AD/HD are assessed on the
WAIS-III using the Digit Span Task (DS), Arithmetic (A) and Letter-NumberSequencing (LNS) test. The Digit Span task has often been used in AD/HD
malingering research due to the observed deficit in working memory common in
many individuals with AD/HD. For this task, individuals are asked to repeat a string
of numbers either in a forward or backward direction. In addition to working
· · memory, attention in two forms is tested with this task; simple attention can be tested
with the Digit Span Forward task, while focused attention can be measured by the
Digit Span Backwards task (Schoechlin & Engel, 2005). An overall age-corrected
scaled score of 5 or less on the Digit Span task is rare and could be interpreted that
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the individual was not putting forth good effort on the assessment (Iverson & Tulsky,
2003). Within the context of malingering, Harrison, Rosenblum, and Currie (2005)
found that none of the participants diagnosed with AD/HD received scores below this
cutoff. Thus, the researchers concluded that the cutoff of a scaled score of 5 or below
could potentially be used as evidence for malingering on an assessment (Harrison et
al., 2005). Another variation to using the Digit Span task is the Reliable Digit Span
(RDS). Although both are commonly used, a meta-analysis completed by Jasinski,
Berry, Shandera, and Clark (201 I), suggest that there is no significant differences in
diagnostic accuracy between the two variations when the suggested cut-off scores are
applied.
Symptom Validity Measures
Digit memory tasks such as the Digit Span Task on version of the Wechsler
Adult Intelligence Scale or the Digit Memory Test (DMT; Hiscock and Hiscock,
1989) have been shown to have moderate sensitivity and strong specificity for
detecting malingered vs. true AD/HD. In general, individuals malingering AD/HD
typically perform significantly poorer on the theses tasks as compared to adults with
AD/HD. The Digit Span Task has also been adapted in the Advanced Clinical
Solutions for the Wechsler Adult Intelligence Scale-Fourth Edition (WAIS-IV;
Wechsler, Coalson, Raiford, 2008) with the Reliable Digit Span Task (Pearson; 2009)
to evaluate the examinee's effort on the neuropsychological testing. For this task, the
examiner calculates a score based on the last trial in which the individual received full
points. The scores from both Forward and Backward are combined to determine an
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overall raw store. The score is compared to normative samples to ultimately result in
a performance summary that can be used when determining the individual's effort on
the task. Both the Digit Span and Reliable Digit Span Task along with another
popular measure, the Test of Malingered Memory (TOMM; Tombaugh, 1996), were
used in the current study.
The TOMM is a memory-based recognition task that has been successfully
used in batteries administered during malingering research for both adults (Solloman
et al., 2010) and children (Constantinou & McCaffery, 2010). Solloman et al. (2010)
found significant differences in TOMM performance between adults attempting to
malinger AD/HD and true AD/HD individuals. During the task, the participant is
shown a series of 50 line drawings. The individual is later asked to recall the images,
by selecting a presented image on 50 two-choice response panels. Conclusions about
why the test is a strong predictor of malingering are credited to the test's design.
Tombaugh (1996) indicates the TOMM's multiple stimuli give examinees the
impression that the task is very difficult. Additionally, the task does not give any
signs to the examinee about what the examiner may be measuring. Lastly, the
examinee receives feedback during the task, so those who are exhibiting full effort,
will learn from the feedback, where those who are not trying or malingering, will not
demonstrate any learning. On the basis of these benefits of the TOMM and its ability
to discriminate between adults with AD/HD and those attempting to malinger
AD/HD, it was included for the current study.
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Psychiatric Feigning Measures

In past research, individuals asked to malinger AD/HD symptoms have not
only showed deficits on measures of executive functions, but also have portrayed
psychiatric symptoms in excess to those reported by normal controls and those with
AD/HD (Booksh, 2005; Harp, Jasinski, Shandera-Oshsner, Mason, Berry, 2011;
Harrison et al., 2007). One popular psychiatric feigning measure used in prior
research on malingered AD/HD is the Miller Forensic Assessment of Symptoms Test
(M-FAST; Miller, 2001). Similar to malingering research with other clinical groups,
M-FAST items were positively endorsed more often by the malingering AD/HD
group in comparison to the true AD/HD group and produced a moderate effect size
(Solloman et al., 2010). Dearth (2007) used the Structured Inventory for Malingered
Symptomatology (SIMS; Widows & Smith, 2005), a psychiatric feigning measure, in
AD/HD malingering research involving adolescents. The researcher found that those
who were asked to malinger AD/HD symptoms demonstrated elevated SIMS scores
indicative of feigning of symptoms. Since the current study will be asking some
participants to purposefully malinger AD/HD symptoms with and without enhanced
AD/HD knowledge, a more comprehensive psychiatric feigning measure like the
SIMS would be of benefit for detecting gross symptom reporting, and was included.
· Current Study

The current study was primarily focused on evaluating the ability of selfreport, neuropsychological, and symptom validity instruments to detect malingered
AD/HD in a college population. To accomplish this main goal, a 2 (malinger vs.
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respond honestly) x 2 (AD/HD enhanced knowledge or non-AD/HD enhanced
knowledge) analogue simulation research design was used with selected self-report,
neuropsychological, psychiatric feigning scales, and symptom validity measures. A
pre-plan-ned power analysis using PASS 11.0 suggested the estimated power in the
study was expected to exceed .90 for a 2x2 factorial design with sixteen participants
per cell (N=64), a moderate effect size (.50), and alpha set at .05.
The study tested the following hypotheses in an attempt to replicate and
_extend prior malingering work for AD/HD self-report scales, rating scales for
executive functioning, neuropsychological measures, psychiatric feigning scales, and
symptom validity measures.
Hypothesis 1: As an internal validity check for the methodology employed,
experimentally enhancing participants' knowledge of AD/HD symptoms was
expected to be associated with elevated scores on a measure of AD/HD knowledge.
Thus, consistent with previous findings regarding the Adult Knowledge of Attention
Deficit Disorder Scale (AKADDS; Watkins & Reilley, 2009), participants in
conditions of enhanced AD/HD knowledge are expected to show a significant
increase in AD/HD symptom knowledge as measured by AKADDS relative to those
in the non-AD/HD knowledge enhancement condition.
Hypothesis 2: Replicating prior findings for AD/HD self-report scales,
malingering groups should score significantly higher than non-malingering groups on
the Current Symptom Scale, CSS, and the Childhood Symptom Scale, CSS-SRF.
Additionally, participants in both malingering conditions should yield CSS and CSS-
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SRF scores that are at least comparable to the published means for AD/HD groups
found in the administration manual. Because extensive AD/HD knowledge is not
needed to malinger on the CSS and CSS-SRF, a significant difference is not expected
on the CSS and CSS-SRF when malingered groups are compared to one another.
Hypothesis 3: The BRJEF-A has yet to be administered in a study of
malingered AD/HD in adults. However, it is expected that the malingering groups
will score significantly higher than non-malingering groups when their BRJEF-A
change scores (post-pre) are evaluated. This is expected given the pattern of excessive
symptom reporting observed for AD/HD self-report measures. Additionally,
participants in the malingering conditions should yield BRJEF-A scores that exceed
the published means for AD/HD groups found in the administration manual.
Knowledge of AD/HD is expected to produce a significant difference between the
malingering groups wherein a higher BRJEF-A score is expected for the AD/HD
knowledge enhanced malingering group relative to other groups.
Hypothesis 4: The D-KEFS has yet to be administered in adult AD/HD
malingering studies. However, the pattern of prior TMT findings for malingered
AD/HD was expected to generalize to the newer D-KEFS tasks. As such, the
malingering groups were expected to score significantly poorer on the D-KEFS tasks
compared to non-malingering groups when standardized scores associated with
completion times were statistically evaluated. An a priori prediction for the D-KEFS
letter-number switching tasks was made based on prior research by Peden (2010).
Specifically, the letter-number switching task is expected to produce a significant
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difference between the malingering groups and non-malingering controls due to its
perceived complexity and difficulty.
Hypothesis Sa: The current study attempted to extend prior research on the

Digit Span test of the Wechsler Adult Intelligence Scale-III by using the Digit Span
test from the Wechsler Adult Intelligence Scale-IV and advanced test analysis using
the Adult Clinical Solutions norms. The pattern of malingering findings for the
WAIS-III Forward and Backward Digit Span task were expected to replicate and be
extended using the WAIS-IV Forward and Backward Digit Span tasks. That is, the
malingering groups were expected to yield lower scaled scores relative to nonmalingering counterparts on those tasks. In addition, malingering groups were
expected to score significantly lower than published means for the AD/HD group
included in the WAIS-IV standardization sample. Finally, performance on the last
trials receiving full credit for the Digit Forward and Backward tasks were combined
to create the Reliable Digit Span test according to the manual for the Advanced
Clinical Solutions for the WAIS-IV. It was expected that the malingering groups
would demonstrate significantly poorer performance on the Reliable Digit Span
relative to non-malingering groups and will be similar to or exceed published norms
for suspected effort as found in the administration manual for the Advanced Clinical
-Solutions for the WAIS-IV.
Hypothesis Sb: The Digit Span Sequencing subtest which is new to the

WAIS-IV has not yet been used in AD/HD malingering research. Nevertheless, a
similar pattern of findings observed on the Digit Forward and Backward tasks was
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expected for the Digit Span Sequencing task given the perceived difficulty of the task
(e.g., multiple complex trials with more working memory demands) and the
continued use of an underperforming malingering strategy. Thus, it was expected that
malingering groups would produce lower scaled scores suggestive of poorer
performance relative to non-malingering groups.
Hypothesis 6: The present study expected to replicate the malingered AD/HD

findings for the TOMM from Soloman et al. (2010). Specifically, it was expected that
the malingering groups would score significantly lower than non-malingering groups
when their TOMM learning trials and recognition trial scores were evaluated.
Additionally, participants in the malingering conditions should yield TOMM scores
that exceed the published means for groups containing individuals with AD/HD as
found in Soloman et al. (2010).
Hypothesis 7: The present study expected to extend the malingered AD/HD

adolescent findings for the SIMS reported by Dearth (2007) in the current adult
malingering AD/HD sample. Specifically, it was expected that malingering groups
would score significantly higher than non-malingering groups when their SIMS total
scores were evaluated. Additionally, participants in the malingering conditions should
yield SIMS scores that meet or exceed the published means for suspected effort as
found in SIMS administration manual.
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Methods
Participants

The sample included I 07 undergraduate students who were recruited to
participate through the SONA-Online Research Sign-Up System as one means for
fulfilling the research/research alternative requirement oflntroductory Psychology
and other participating psychology courses. Participants were 25 males (23%) and 82
females (77%) ranging in age from ages 18 to 45 years. Self-reported class standing
was as follows: freshman (51 %), sophomore (24%),junior (10%), and senior (15%).
The etlmic background of the participants as selfreported were as follows: Native
American or Alaskan Native (I%), African American (6%), Asian/Pacific Islander
(3%), Hispanic (I%), and Caucasian (89%). Students without a prior AD/HD
diagnosis and who have not received or are currently receiving treatment for AD/HD
were included in the study. Recruited participants were randomly assigned to one of
four groups: Informed AD/HD Malingers, Informed Control Malingers, AD/HD
Informed Non-Malingers, and AD/HD Control Non-Malingers.
Procedures

All protocol and informed consent documents were approved by the
Morehead State University Institutional Review Board. Each individual in the
research study completed a research session of approximately 2-hoursa See Figure 1
for a schematic for the research protocol. As part of the pre-test battery, each
participant completed a personal history form, and was administered the
symptoms/diagnosis subscale of the Adult Knowledge of Attention Deficit Disorder
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Scale (AKADDS; Watkins & Reilley, 2009) to assess the participant's current
knowledge of AD/HD. The Childhood Symptom Scale- Self Report (CSS-SRF;
Barkley & Murphy, 1998) and the Current Symptoms Scale (Murphy & Barkley,
1996a, 1996b) were administered to determine if the participant was free from
clinical levels of AD/HD symptoms and to establish a baseline level of reported
AD/HD symptoms. Finally, the BRIEF-A was administered to obtain a baseline of
self-reported executive functioning problems. After this assessment, participants
received a brief reading. The AD/HD knowledge enhanced groups received the
Center for Disease Control (CDC) AD/HD Symptom Criteria (CDC & National
Center on Birth Defects and Developmental Disabilities, 2001) to read and the nonAD/HD knowledge enhancement groups received an excerpt from the MTVu College
Mental Health Summary (The Jed Foundation and MtvU, 2006) that addressed mental
health issues generally on college campuses, but did not address AD/HD specifically.
Similar to other research studies (e.g., Solloman et al., 2010), participants were given
5 minutes to read the assigned reading, and then were asked to complete a short quiz
to ensure they read and comprehended the content of the reading. A quiz score of
70% was used as the criterion for further inclusion of participants' data for statistical
analysis. Following the administration of the quizzes on the reading, participants were
asked to again complete the AKADDS to reassess their AD/HD knowledge.
Following completion of the AKADDS, non-malingering participants were
given instructions to complete all post-study measures to the best of their ability and
to respond honestly. Malingering Participants were given a scenario (provided below)
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and asked to use the information they received from the articles, and fill out the
following measures as the person in the scenario who has AD/HD (Quinn, 2003).
"Imaging yourself having trouble in school. Things aren't working out as you
planned, but your counselor's only advice is to buckle down. You want to get
some help. You hear about adult AD/HD on a television show. When talking
to a friend about it, your friend tells you that you could get special
accommodations from the university, like untimed tests and rescheduling of
exams if two are given on the same day. Your friend adds that the stimulant
medications that are generally prescribed have minimal side effects and that
you can take the medication only when you need it, just for school. You
decide to read a book on ADHD. You find that some ADHD adults even
collect social security benefits. You conclude that you have enough of the
symptoms. You convince yourself that you have ADHD. You go to the doctor
and you really want to get help. In order to get these benefits, you need to
convincingly act like a person who has ADHD."
After being presented with the scenario, malingering participants were asked
to give the researcher an oral summary (See Appendix A) regarding whats/he
understands they are to do for this part of the study as a manipulation check. Control
subjects were asked to verbally explain the task as well, but were not provided a
scenario (See Appendix B). In addition to participants' explanation of what the task
involved, the researcher included a Likert-type scale ranging from I (No
Understanding of Task) to 5 (Perfect Understanding of Task) to evaluate the level at
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which the participant appeared to have understood the task. Additionally there was a
note section for the researcher to record qualitative information regarding the rating
assigned to the participant. For example, any problems or issues that arose during the
test administration were noted such as interruptions or distractions (i.e. voices outside
the room), temperature issues (i.e., was the room too hot or too cold for the
participant), significant observations about participant behavior, and any information
regarding why the researcher suspected the participant of not displaying acceptable
effort.
All participants received research credit for completing the testing in whole or
in part. The researcher provided 8 door prizes in a raffle for those who completed the
assessment. Malingering groups were told that the door prize will only be offered to
those who successfully malingered ADHD, however, consistent with the approved
IRB protocol, the researcher randomly chose 8 individuals to receive door prizes (2
from each of the 4 groups) from the pool of individuals that completed the research
session. The door prize was a $10.00 gift certificate to the campus bookstore.
Tests Administered
All study participants were asked to complete the following self-report
measures, symptom validity measures, psychiatric feigning measure, and
neuropsychological measures.
A Personal History Questionnaire was administered as part of the pre-test
battery of testing to all participants. This questionnaire included demographic
information (e.g.,. age, sex, ethnicity, grade level, etc), in addition to questions
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regarding past history of learning disorders, AD/HD status, medical and mental health
history, substance use, and current academics.
The Current Symptoms Scales (CSS; Barkley & Murphy, 1998) was
administered as part of the pre and post-test battery to assess self-reported current
AD/HD symptoms. Previous studies have shown the CSS has acceptable internal
consistency of a.> .80; Barkley & Murphy (1998). The CSS has 18 items (IO social
functioning and 8 Oppositional Defiance Disorder (ODD) items) that are rated on 0-3
point scale using the responses 'Never or Rarely, Sometimes, Often, and Very Often.'
Total scores for AD/HD Inattentive, AD/HD Hyperactivity, and AD/HD Combined
symptom scales were calculated. These scores were additionally compared to
established clinical AD/HD cutoffs and impairment ratings to determine non-AD/HD
status (pre-test) and to determine the severity of the self-reported AD/HD symptoms
in the post-test battery.
The Childhood Symptom Scale- Self Report (CSS-SRF; Barkley & Murphy,
I 998) was included in the pre and post-test battery to establish a low probability of
AD/HD (pre-test) and to evaluate self-reported AD/HD symptoms in the post-test
battery. Similar to the CSS, the CSS-SRF has 18 items covering DSM-IV criteria for
AD/HD. Using the same 0-3 point scale as the CSS, participants respond to CSSSRF items according to how well the statement describes them as a child between the
ages of5-12 years. Again, this instrument includes a section that asks the participant
how these problems they endorsed affected their other activities when they were
between 5-12 years of age. Similar to the CSS, total scores for AD/HD Inattentive,
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AD/HD Hyperactivity, and AD/HD Combined scales were calculated. These scores
were additionally compared to established clinical AD/HD cutoffs and impairment
ratings to determine non-AD/HD status (pre-test) and to determine the severity of the
self-reported AD/HD symptoms in the post-test battery. Previous studies have shown
the CSS-SRF has an internal consistency of a> .80; Barkley & Murphy (1998).
The Adult Knowledge ofAttention Deficit Disorder Scale (AKADDS;
Watkins & Reilley, 2009), inquires about knowledge of adult AD/HD and is a
modified version of the child AD/HD knowledge scale (Sciutto, Trejersen, and
Bender Frank, 2000). The AKADDS includes 34 'True, False, or I don't know'
formatted questions that cover symptoms, treatment, and associated features of adult
AD/HD. Previous studies have shown that this study has acceptable internal
consistency (a= .62-.82) and has good convergence with the KADDS (correlations
.82-.92) (Dahmane & Reilley, 2009; Watkins & Reilley, 2009). A 9-item subscale
from the AKADDS pertaining to AD/HD symptoms/diagnosis was administered to
participants to evaluate the participants' knowledge about ADHD before and after the
AD/HD knowledge intervention. Change scores across the pre-post administration of
the 9-item AKADDSA subscale was calculated by subtracting the pre-test scores to
those from the post-test battery.
The Behavior Rating Inventory ofExecutive Functioning- Adult Version
(BRIEF-A; Roth, Isquith, & Gioia, 2005) was administered in the pre and post-test
battery to evaluate self-reported executive functioning problems. The Self-Report
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form of the BRIEF-A was used and contained 75-multiple choice questions. These
items were distributed across nine clinical scales [Inhibit, Shift, Self-Monitor,
Working Memory, Plan/Organize, Task Monitor, Organization of Materials] and
three validity scales [Negativity, Infrequency, Inconsistency]. The BRIEF-A has
acceptable internal consistency (Roth, Isquith, and Gioia, 2005) ranging 0.73-0.90 for
normal samples and 0.80-0.94 for mixed samples of clinical and healthy adults.
Additionally, researchers have found significant difference between medicated and
unmedicated adults with AD/HD on the clinical scales oflnhibit, Self-Monitor,
Initiate, Working Memory, Plan/Organize, and Task Monitor. The measure has been
successfully used in AD/HD research regarding stimulant research (Biederman, Mick,
Fried, Wilner, Spencer, & Faraone, 2011), but has not been used in AD/HD
malingering studies to date. For this study, scores for the BRIEF-A composite scores,
and clinical scales were calculated and inspected akin to Reid, Karim, McCrory, &
Carpenter (2010) and were compared to the normative AD/HD sample reported by
Roth, Isquith, and Gioia (2005).
The Test ofMemory Malingering (TOMM; Tombaugh, 1996) is a symptom
validity test commonly used in clinical practice. Participants completing the TOMM
were asked to complete the two separate learning trials comprised of 50 line drawing
target items and 50 line drawing recognition items and a retention trial comprised of
50 recognition items. The first two trials were administered to the participants
consecutively. Another counterbalanced task was administered before utilizing the
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TOMM retention trial to fulfill the needed time gap as outlined in the administrative
manual. Scores on the learning trials and the recognition trial were subjected to
statistical analysis to evaluate the research hypothesis involving the TOMM.
The Structured Inventory for Malingered Symptomatology (SIMS; Widows &

Smith, 2005) is a 75 item inventory designed to gauge malingered psychopathology
and cognitive functioning. The items on the SIMS were distributed across five scales
(Psychosis, Neurologic Impairment, Amnestic Disorders, Low Intelligence, and
Affective Disorder) contained 15 statements to which participants responded either
True or False. Content assessed by the different scales ranged from bizarre symptoms
(i.e. "I have noticed that my shadow dances wildly even though I remain still") to
symptoms that are uncommonly endorsed by the clinical population (i.e. "I believe
that the government has installed cameras in stop lights to spy on me"). Additionally,
Amnestic Disorder items measured general knowledge using items such as "The
capital ofltaly is Hungary." Each SIMS response was associated with a value of Oor
1 and was subsequently assigned to one of the individual SIMS scales, and then
ultimately summed into a total SIMS score. The SIMS Total Score has adequate
reported reliability with Cronbach's alpha= 0.88.
The Wechsler Adult Intelligence Scale- Fourth edition (WAIS-IV; Wechsler,
2()08) Digit Span subtest was administered to assess auditory short-term memory. The

Digit Span forward and backward tasks have been traditionally used in AD/HD
malingering studies with success in detection of possible malingering due to
exaggerated poor performance (Inman & Berry, 2002). To standardize the
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administration of this orally administered task, participants listened to a string of
digits that were pre-recorded by a female voice with a rate of about one digit every
two seconds in order to increase standardization. When the recorded string of
numbers was completed, the participant was asked to repeat the numbers in a set
order. For the first condition (Digits Forward), individuals were asked to repeat the
numbers exactly as the recording presented them. In the second condition (Digits
Backwards), individuals were asked to repeat the string of numbers in the reverse
order in which they were presented. In the last condition (Sequencing), the individual
arranged the number in numerical order including any repeated digits (i.e. item is 1-56-4-1, the correct response would be 1-1-4-5-6) as directed. The raw Digit Span
scores (Forward, Backward, and Sequencing) were calculated and converted to
Standard Scores based on standardized methods outlined in the WAIS-IV
Administration Manual. The Reliable Digit Span score was also calculated using the
procedure outlined in the Advanced Clinical Solutions for the WAIS-IV
Administration Manual.
The Delis-Kaplan Executive Functioning System Trail Making Task (D-KEFS

TMT; Delis, Kaplan, Kramer, 2001a) is a modification of the original trail making
task and involved five conditions. This modification removed the need for 'clinical
hunches' to hypothesize about an individual's performance by assessing visual
scanning, number sequencing, letter sequencing, and motor speed abilities; both in
isolation and in combination (i.e., Condition Four - Letter-Number Switching Task).
Raw scores were comprised of the completion time (in seconds) and were converted
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to raw scores based on standardized practices as stated in the examiner's manual. The
D-KEFS TMT has acceptable internal consistency across conditions (a > .70) and has
good test-retest reliability (r 12 =0.61, 0.55, 0.59, 0.60, 0.59 respectively).
Results

Statistical Analysis Plan
All scoring of standardized measures were completed according to the
standardized instructions included in the manuals for each assessment instrument. To
ensure accuracy of scoring and data-entry from psychological measures and selfreport inventories, cross-checking of scoring of psychological measures was
conducted by research staff and a random subset of the data-entry was inspected to
ensure accuracy of data entry.
Both Multivariate Analysis of Variance (MANOVA) and univariate Analysis
of Variance (ANOV A) procedures were conducted to initially test the research
hypotheses. Planned and post-hoc t-tests were used as a follow-up to the
MANOV AlANOV A analyses to test research hypotheses. The underlying
assumptions for each analysis to be performed were evaluated to determine
acceptability of the analyses and non-parametric analyses were considered for any
serious violations of the assumptions for a specific statistical test. An adjusted alpha
of0.01 was used to redace the likelihood ofa Type I error given the number of
statistical tests that were conducted.
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Analyses for Hypotheses Involving AD/HD Self-Report Measures
As can be observed in Table 2, there were no pre-existing differences between
groups' prior knowledge of ADHD symptoms assessed by the AKADDS (F (3,79) =
.86, p = .468). Similarly, no pre-existing differences emerged for groups' childhood
AD/HD symptoms, as measured by the Barkly Murphy Childhood Symptom ScaleSelf Report Form (F (3,79) = .25,p = .863)., and current AD/HD symptoms, as
reported on the Barkley Murphy Current Symptom Scale (F(3,79) = .36,p = .784).
Adult Knowledge of Attention-Deficit Disorder Scale (AKADDS).
Hypothesis I predicted that participants in conditions of enhanced AD/HD
knowledge would display a significant increase in AD/HD symptom knowledge on
the AKADDS symptom subscale scores relative to those in the non-AD/HD
knowledge enhancement conditions. An ANOVA conducted on the residualized
AKADDS change scores (post - pre test scores) indicated a significant main effect
between groups, F (3, 79)=15.26, p = 0.001. Consistent with Hypothesis 1, the mean
AKADDS change score for the collapsed ADHD knowledge enhanced (CDC) groups
(M=3.59) was statistically higher than average AKADDS change score for the nonADHD knowledge enhanced (MTVu) groups (M=0.47) according to planned t-test
analysis, t (81) = 7.12,p = 0.001. There were no significant differences between the
knowledge enhanced groups (t (46) = 0.45, p = 0.64) or between non-knowledge
enhanced groups (t (33) = 0.78, p = 0.44). Thus, Hypothesis 1 was fully supported.
Barkley & Murphy Current Symptom Scale and Childhood Symptoms Scale.
Hypothesis 2 was supported as malingering groups scored significantly higher than
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non-malingering groups on the Current Symptom Scale, (CSS) and the Childhood
Symptom Scale, (CSS-SRF). Specifically, the mean CSS change score of the
collapsed malingering groups (M=30.29) was significantly higher than the mean CSS
score for the collapsed non-malingering groups (M = -1.31) according to planned ttest analysis, t(81)=7.29,p=0.00I. Similarly, the mean CSS-SRF change score for the
collapsed malingering groups (M=29.42) was significantly higher than the mean CSSSRF change score for the collapsed non-malingering groups (M = -1.26) according to
planned t-test analysis, t (81) = 7.74, p=0.001. As can be seen in Table 3, the mean
post-test CSS-SRF score for the collapsed malingering group (M = 45.67) exceeds the
highest reported cut score based on age and gender (M= 38.80) for a positive
screening for childhood AD/HD symptoms as listed in the manual, whereas the mean
post-test score for the collapsed non-malingering group (M = 15.55) did not.
Similarly, Table 4 shows the mean post-test CSS score for the collapsed malingering
group (M = 44.24) exceeds the highest reported cut score based on age and gender (M
= 27.80) for a positive AD/HD screening as listed in the manual, whereas the mean
post-test score for the collapsed non-malingering group (M = 11.79) did not.
Behavior Rating Inventory for Executive Functioning- Adult Version {BRIEF-

Partial support was found for the three predictions associated with Hypothesis 3.
First, malingering groups scored significantly higher than non-malingering groups
when BRIEF-A change scores (post-pre BRIEF-A) were statistically compared using
separate sets ofMANOVA and ANOVA analyses with planned t-tests for BRIEF-A
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scales associated with the Behavioral Regulation Index (BRI) and the Metacognition
Index (MI), respectively. The MANOVA for the set ofresidualized (post-pre)
BRIEF-A Behavioral Regulation Index (BRI) and subscales assessing difficulties
Inhibiting, Task Shifting, Emotional Control, and Self-Monitoring was significant
with Wilks' A (.54), F= 3.49, p < .001, partial eta squared= .19. Univariate AN OVA
analyses yielded significant results for the total BRI score and all associated subscales
(all Fs > 8.04,p < .001) between groups. Table 5 lists the residualized means for the
BRI Total score and associated subscales for each of the malingering and nonmalingering groups. To simplify presentation of findings, malingering groups and
non-malingering groups were collapsed as statistical differences did not emerge when
mean scores were tested within malingering and non-malingering groups,
respectively. As predicted, !-test analyses indicated that malingering groups BRIEF-A
scores increased significantly from baseline in contrast to non-malingering groups (all
ps < .001) for the BRI total score (malingering M = 13.12; non-malingering M = -

0.50), and associated subscales measuring difficulties Inhibiting (malingering M =
15.07; non-malingering M = -0.26), Task Shifting (malingering M= 12.98; nonmalingering M =1.19), Emotional Control (malingering M = 6.63; non-malingering M
= -1.19), and Self-Monitoring (malingering M = 13 .34; non-malingering M = -0.19).
A similar pattern ofresults in the predicted direction emerged from the
MANOVA for the set ofresidualized (post-pre) BRIEF-A Metacognition Index (MI)
and associated subscales assessing difficulties Initiating, Working Memory,
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Planning/Organizing, Task Monitoring, and Organization of Materials with Wilks'
A (.43), F = 4.02,p < .001, partial eta squared= .24. Univariate AN OVA analyses
yielded significant results for the total MI score and all associated subscales (all Fs >

12.55,p < .001) between groups. Table 6 lists the means for each of the malingering
and non-malingering groups for the MI Total score and the means scores for the
associated subscales. As before, t-test analyses indicated that malingering groups'
BRIEF-A scores significantly increased from baseline in contrast to non-malingering
groups (all ps < .001) for the MI total score (malingering M = 18.37; non-malingering
M = -0.62), and associated subscales measuring difficulties Initiating (malingering M

= 13.12; non-malingering M= -0.26), Working Memory (malingering M = 20.71;
non-malingering M = -0.50), Planning/Organizing (malingering M = 17.34; nonmalingering M = 0.10), Task Monitoring (malingering M = 19.07; non-malingering M
= -0.48), and Organization of Materials (malingering M = 12.37; non-malingering M
= -0.98).
Finally, contrary to predictions, malingerers with or without AD/HD
knowledge did not yield BRIEF-A scores that were significantly higher (all ps > .05)
than the published BRIEF-A means from a sample of27 non-medicated adults with
AD/HD reported in the administration manual. This finding was consistent for both
BRI and MI as well as for all associated subscales as can be seen in Table 5 and 6.
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Analyses for Hypotheses Involving Neuropsychological Measures
Delis-Kaplan Executive Functioning System Trail Making Task (D-KEFS).
Partial support was found for the predictions associated with Hypothesis 4.
First, support was found for the prediction that malingering groups would score
significantly higher than non-malingering groups on the D-KEFS. When the set ofDKEFS tasks (I: Visual Scanning, 2: Number Sequencing, 3: Letter Sequencing, 4:
Number-Letter Switching, and 5: Motor Speed) were considered jointly using their

•

scaled scores, the initial MANOVA procedure was significant, Wilks' A (.55), F =
3.28, p = .001, partial eta squared= .I 8. Univariate ANOV A analyses using D-KEFS
scaled scores yielded significant (all Fs > 5.53,p < .01) differences between groups
for all D-KEFS Trials except Trial 4: Number-Letter Switching (F (3, 79) = 2.44,p =
.07). As can be seen in Table 7, malingerers 1 performed significantly worse than nonmalingerers as evidenced by lower D-KEFS scaled scores on tasks involving Visual
Scanning (malingering M = 6.56; non-malingering M = 10.64), Number-Sequencing
malingering (M = 7.66; non-malingering M = l 0.69), Letter Sequencing (malingering
M= 7.80; non-malingering M= 11.14), and Motor Speed (malingering M= 9.80;

non-malingering M=l 1.33). The difference between malingerers (M= 7.95) and nonmalingerers (M= 9.74) on the fc:mrth D-KEFS task that involved number-letter
switching approached significance (t (81) = 2.56,p = .013).

'To simplify presentation of findings, malingering groups and non-malingering
groups were collapsed as statistical differences did not emerge when mean scaled
scores were tested within malingering and non-malingering groups, respectively.
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Analyses for Hypotheses Involving Symptom Validity Measures
Digit Span Test from Wechsler Adult Intelligence Scale - Fourth Edition.
Partial support was found for the predictions associated with Hypothesis 5. A
significant group level multivariate effect did not emerge (Wilks' A (. 79), F = 1.22, p.
= .249, partial eta squared= .08.) for performance indicators associated with the Digit
Span Tasks (Digits Forward, Digits Backward, Digit Span Sequencing, Reliable Digit
Span). Univariate ANOVA analyses indicated group level differences approaching
significance for the Digit Span Total Score, (F (3, 79) = 3.44,p = .021), Digit Span
Sequencing Task (F (3, 79) = 3.54,p = .018), and Reliable Digit Span Score (F (3,
79) = 3.54,p = .018). Subsequent t-test analyses comparing the collapsed mean score
of malingerers vs. non-malingerers supported predictions that malingers would have
worse overall performance on the Digit Span Task as evidenced by significantly
lower Digit Span Total Scores (t (81) = -2.79, p = .006). Similarly, predictions
regarding the Digit Span Sequencing were supported as malingerers scored
significantly lower on this new task relative to non-malingerers, (t (81) = -2.82, p =
.006). Finally, although the difference between malingerers and non-malingerers
approached significance (t (81) = -2.52,p = .014), malingerers with enhanced AD/HD
knowledge (M = 7.65) did score significantly lower than their non-malingering (M =
9.68) counterparts. Individual participant analysis of the Reliable Digit Span scores
identified a total of9 participants (11 %) as potentially malingering after scoring
below the minimum cut-off for scores with questionable effort according to the ACS
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Manual. The CDC Malingering AD/HD group included 6 participants (26%) and the
MtvU Malingering AD/HD group included 2 participants (11 %) that were labeled as
potentially malingering based on the RDS score. There was one participant that was
incorrectly identified at potentially malingering in the CDC Honest Responding group
due to scoring below the cut-off score.
Test of Memory Malingering.
Hypothesis 6 was supported. A significant group level multivariate effect was found
(Wilks' A (.65), F= 4.06,p = .001, partial eta squared= .13.) when performance
indicators associated with the TOMM tasks (Learning Trial I, Learning Trial 2,
Retention) were considered jointly. Univariate AN OVA analyses yielded significant
(all Fs > 5.85,p < .001) group differences for both TOMM Learning Trials as well
as the Retention trial. As can be found in Table 9, subsequent !-test analyses indicated
that malingerers 2 performed significantly worse (all ts> 4.24, withps < .001) than
non-malingerers on TOMM Learning Trial I (malingering M = 78.3; non-malingering
M = 98.3), Trial 2 (M = 85.3; non-malingering M = 99.9), and the Retention trial

(malingering M= 81.2; non-malingering M = 99.9). Finally, consistent with
predictions, malingerers yielded TOMM scores that were significantly lower (all ts>
2.68,ps < .01) than published TOMM means for an AD/HD group from Solloman et

2

To simplify presentation of findings, malingering groups and non-malingering
groups were collapsed as s\atistical differences did not emerge when mean scaled
scores were tested within malingering and non-malingering groups, respectively.
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al. (2010). This finding was consistent for Trial 1, Trial 2, and the Retention Trial for
malingerers with and without enhanced AD/HD knowledge as can be seen in Table 9.
Structured Inventory of Malingered Symptomatology (SIMS).
Hypothesis 6 was partially supported. Although a significant group level
multivariate effect approached significance (Wilks' A (.66), F= I.74,p = .036, partial
eta squared= .86.), univariate ANOVA analyses yielded significant (all Fs > 4.26,p
< .01) group differences for all SIMS subcales except the Affective Disorder subscale
where F (3, 74) = 1.18, p = .322. As can be found in Table 10, subsequent I-test
analyses indicated that consistent with expectations malingerers scored significantly
higher than non-malingerers on the SIMS Total Score (t (76) = 4.45, p = .001),
Psychotic symptoms (t (76) = 3.50, p = .001), neuropsychological symptoms (t (76) =
4.25, p = .001), amnestic symptoms (t (76) = 3.83, p = .001), low intellectual
functioning (t (76) = 3.26, p = .002), but not for affective disorder symptoms (t (76) =
1.95, p = .054). Individual participant analysis of the SIMS Total Score indicated that
ten CDC Malingering participants (4 5%), two CDC Control participants (9% ), five
MTVu Mlaingering participants (28%), and zero MTVu Control participants (0%)
were classified as potentially malingering with a Total Score exceeding 14.
Discussion

The current study used a lab-based simulation research design to evaluate the
susceptibility of commonly used AD/HD rating scales, as well popular
neuropsychological, and symptom validity tests to malingered AD/HD in a college
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population. The results of the present inquiry further the science of clinical
psychology by adding to the research base of commonly used measures for screening
and assessing adults with suspected AD/HD. In addition, it is one of the first studies
to experimentally evaluate malingered AD/HD with respect to new, promising
instruments, including a self-report (BRIEF-A) and a paper-and-pencil (D-KEFS)
measure of executive dysfunction, and symptom validity measures (WAIS-IV Digit
Span and Reliable Digit Span task, and the SIMS).
The present study found support for Hypothesis I as increases in AD/HD
symptom knowledge measured by the AKADDS were associated with a brief review
of a widely available and free version of the AD/HD symptom criteria from the DSMIV-TR. This finding was consistent with previous research work involving the
AKADDS (Watkins & Reilley, 2009) as well as broader psychoeducational attempts
to improve mental health practitioners' knowledge about the disorder (Sollomon et
al., 201 0; Watkins & Reilley, 2009) Evidence in support of Hypothesis 2 was
garnered and illustrates the high susceptibility of self-report AD/HD rating scales to
malingered AD/HD when response distortion indicators are not included.
Specifically, both retrospective reporting of childhood AD/HD symptoms (Barkley &
Murphy CSS-SRF) and complaints of current AD/HD symptoms (Barkley & Murphy
CSS) were able to be easily manipulated and falsified as reflective of AD/HD by
college students with and without experimentally enhanced knowledge of AD/HD.
These findings support prior work by Booksh (2005), Jachimowicz & Geiselman
(2004), Quinn (2003), and Sollomon et al. (20 I 0). When students attempting to
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malinger AD/HD were asked to consider the wider domain of executive dysfunction,
their malingering attempts only partially met with success as evident by partial
support of Hypothesis 3. While malingering groups scored significantly higher than
non-malingerers on the BRIEF-A scales, including the BRI, MI, as well as
corresponding subscales, they did not score significantly higher than published
AD/HD norms. In fact, malingered AD/HD groups scored well below published
normative data from a group ofunmedicated adults with AD/HD. Thus, additional
research on the BRIEF-A is needed before determining its potential utility in
discriminating between clinical AD/HD and malingered AD/HD samples.
Hypothesis 4 involved predictions for a paper-and-pencil neuropsychological
measure of executive dysfunction, an expected area of cognitive weakness in adults
with AD/HD. Previous studies have focused on a traditional trail making test (DKEFS TMT; Delis, Kaplan, Kramer, 2001a) as one means of assessing executive
dysfunction. However, the traditional Trail Making Test (Parts A and B) confounds
visual scanning, motor control, letter-number and number-number sequencing
whereas modern versions of the task like the D-KEFS (Delis, Kaplan, Kramer, 2001a)
allow for separate performance assessments of the task components. Partial support
was found for Hypothesis 4 as malingerers of AD/HD performed significantly worse
on visual scanning, number sequencing, letter sequencing, and motor speed
components, and approached statistical significance for number-letter switching.
Thus, the present study found support for malingerers to score significantly more
poorly on 4 of 5 D-KEFS tasks, but did not support the findings of Peden (2010)
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findings regarding letter-number switching being significantly poorer in AD/HD
populations relative to non-AD/HD controls. The lack of a significant finding for
number-letter sequencing from the D-KEFS could be due to reduced statistical power
due to a reduced alpha level ·to control Type 1 error rather than lack of a true
difference between malingerers and non-malingers. Additional research will be
needed to evaluate this speculation.
Partial support was also found for Hypothesis 5 which involved attempts to
malinger auditory working memory as measured by the new WAIS-IV Digit Span
task, including the new Digit Span Sequencing task. The results of the present study
did not overwhelmingly support prior malingering research (e.g., Booksh, 2005;
Inman and Berry, 2002; Solloman et al., 2010) involving individual Digits Forward
and Digit Span tasks; however, analyses of the Total Digit Span score as well as Digit
Span Sequencing tasks did show significant differences in the predicted difference.
The current study did not provide support regarding group level differences for the
Reliable Digit Span Task nor did many differences emerge between the AD/HD
normative group and the malingered AD/HD groups. The latter could be a
comparison issue as the clinical AD/HD group reported in the manual was a
combined sample of medicated and unmedicated adults with AD/HD. Additional
research will be needed with adequate clinical samples of unmedicated and medicated
adults with AD/HD to evaluate this speculation.
With respect to symptom validity measures, support was found for Hypothesis
6 involving the Test of Memory Malingering (TOMM). The results from the current
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study support the findings of the Solloman et al. (2010) study. Specifically,
participants who attempted to malinger AD/HD in the present study performed
significantly worse on learning and retention trials in comparison to the clinical
AD/HD group means from the Solloman et al. (2000) study. Thus, future malingering
studies should consider inclusion of the TOMM to determine ifit continues to
demonstrate promise as a symptom validity measure that may be helpful in
determining clinically valid vs. malingered AD/HD. Similarly, malingerers also
scored significantly higher on the Structured Inventory of Malingered
Symptomatology (SIMS) in contrast to the non-malingerers and 28% to 45% of
malingerers without and with enhanced AD/HD knowledge were identified as
malingerers compared to 0-9% of control participants, respectively. Assuming these
results are replicable, future research may wish to consider the comparative efficacy
of including specific symptom validity measures whether self-report like the SIMS or
performance based like the TOMM as part of AD/HD assessment battery.
The current study was not without limitations. Unlike some prior studies
(Kibby & Cohen, 2008; Quinn, 2003; Solloman et al, 2010), the present inquiry did
not use a clinical AD/HD group which limits clinical generalizability of findings.
Although new AD/HD malingering were generated for the D-KEFS and the SIMS, a
limitation is the lack of direct comparability of malingering groups to adults with
clinical AD/HD on these measures. The current study chose to include the DKEFS
TMT instead of the original Trail Making Task due to the advantage of isolating the
specific functional behaviors associated of each task. That is, inclusion of the
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measures like the D-KEFS allows the clinician to isolate specific performance
difficulties on a multifaceted task which is advantageous for enhancing our
neuropsychological understanding of the specific cognitive and motor difficulties
associated with the disorder. Similarly, the SIMS was successful in the correct study
by correctly classifying malingers as malingering 28-45% of the time, but it is unclear
and remains as open question as to how often an individual will be incorrectly
classified on the SIMS. Finally, a larger sample size (N>29) and increased power for
statistical tests would have be preferred to provide maximum comparison ability.
Unfortunately, a reduction in the alpha to correct for multiple comparisons may have
led to several unclear outcomes that approached statistical significance rather than a
clearer set of findings in a few cases. Identification of individuals that are malingering
AD/HD in university settings may remain a complex process due to the variability in
the methods in which clinicians assess for the disorder. As found in numerous studies,
including the current study, self-reports alone are not sufficient for diagnostic clarity
due to the instruments general susceptibility to malingering. The present study
provides data on a number of additional inventories and modem assessment measures
(D-KEFS, TOMM, SIMS) that should be considered both in research as well in
clinical work for empirically informing our clinical decision making regarding
feigning or malingering AD/HD.
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Appendix A
Instructions Prior to Filling Out Post-Tests for Malingering Participants

Task:
Imagine yourself having trouble in school. Things aren't working out as you planned,
but your counselor's only advice is to buckle down. You want to get some help. You
hear about adult AD/HD on a television show. When talking to a friend about it, your
friend tells you that you could get special accommodations from the university, like ·
untimed tests and rescheduling of exams if two are given on the same day. Your
friend adds that the stimulant medications that are generally prescribed have minimal
side effects and that you can take the medication only when you need it, just for
school. You decide to read a book on ADHD. You find that some ADHD adults even
collect social security benefits. You conclude that you have enough of the symptoms.
You convince yourself that you have ADHD. You go to the doctor and you.really
want to get help. In order to get these benefits, you need to convincingly act like a
person who has ADHD
Directions:
Using the Information Reading you were presented Previously, and imagining
yourself as the person in the above scenario, try to fill out the following
questionnaires and complete the following task convincingly acting like someone
who has ADHD.
Tell your researcher a summary of what you understand you are supposed to do for
this part of the study.
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Appendix B

Instructions Prior to Filling Out Post-Tests for Control Participants
Task:
Fill out the following questionnaires and complete the following tasks honestly using
the knowledge you gained from the article.

Tell your researcher a summary of what you understand you are supposed to do for
this part of the study.
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Appendix C

Researcher Evaluation ofParticipant's Performance
Rate the Participants Motivation to complete the study (please circle) and
provide notes about the· study (problems, mistakes, temperature issues, etc.)

Low
Notes:

1

2

3

4

5

6

7

8

9

10

High
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AppendixD
Figure I

Pre-Test Battery:

Protocol

AKADDS
CSS & CSS-SF
BRIEF-A

AD/HD
Knowledge
Enhancement
CDC

~
Quiz
Malingering

All will be repeated on

Post-Testing

s

AKADDS-

Quiz Non-

L

Control: nonAD/HD
Knowledge
MTVu Article

~ ~

Quiz
Malingering

Malingering

I

Quiz Non-

Malingering

I
I

\

Post Test Battery
( Couterbalanced Between
Subjects)
TOMM:
Trials 1&2

I SIMS I
TOMM:
Retention
Digit Span
CSS and
CSS-SRF•

BRIEF-A*
D-KEFS
TMT
Post
Malingering
Check

66

Appendix E
Table 1
Participant Demographic Information by Condition

n

Age

MSUGPA

Participant Group
Mean

S.D.

Mean

S.D.

42

20.61

5.43

3.20

0.52

23

20.52

4.91

3.21

0.54

MTVU Malingering 19

20.58

6.02

3.17

0.48

41

20.29

4.15

3.17

0.57

CDC Control

25

21.04

5.13

3.15

0.61

MTVU Control

16

19.25

1.57

3.20

0.54

Malingering Collapsed
CDC Malingering

Control Collapsed
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AppendixF
Table 2
AK.ADDS Scores by Condition

n

Pre-AK.ADDS

Post-AKADDS

Participant Group
Mean

S.D.

Mean

S.D.

42

3.71

1.69

5.70

1.91

23

3.57

1.83

7.00*

0.95

MTVU Malingering 19

3.79

1.55

4.15

1.54

41

3.02

1.91

5.64

2.23

CDC Control

25

3.00

1.85

6.72*

1.24

MTVU Control

16

3.13

2.10

3.94

2.46

Malingering Collapsed
CDC Malingering

Control Collapsed

* indicating sig. t-test difference from pre-test mean at p < .0 I
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Table 3

CSS-SF Scores by Condition

n

Pre-CSS-SF

Post-CSS-SF

Participant Group
Mean

S.D.

Mean

S.D.

42

16.24

15.78

45.66

24.52

23

16.35

14.18

45.96*

25.12

MTVU Malingering 19

15.63

17.35

43.37*

24.80

41

16.81

12.40

15.55

12.10

CDC Control

25

18.44

11.51

17.16*

11.60

MTVU Control

16

14.88

13.91

13.44*

13.15

Malingering Collapsed
CDC Malingering

Control Collapsed

* indicating sig. t-test difference from pre-test mean at p < .01
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AppendixH
Table 4
CSS Scores by Condition

n

Pre-CSS

Post-CSS

Participant Group
Mean

S.D.

Mean

S.D.

42

13.95

11.07

44.24

25.86

23

14.17

12.33

45.74*

26.81

MTVU Malingering 19

13.63

9.29

40.79*

25.13

41

13.10

7.32

11.79

7.06

CDC Control

25

14.20

7.16

12.92*

7.60

MTVU Control

16

11.38

7.71

9.94*

6.16

Malingering Collapsed
CDC Malingering

Control Collapsed

* indicating sig. t-test difference from pre-test mean at p < .01
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Appendix I
Table 5
BRIEF-A BRI Change Scores (Post-Pre) by Condition

Inhibiting

Participant Group

n

Malingering Collapsed 42

CDC Malingering 23

MTVU Malingering 19

Control Collapsed

CDC Control

41

25

MTVU Control 16

Task
SelfEmotional
Shifting Control Monitoring

Mean

Mean

(S.D.)

(S.D.)

(S.D.)

(S.D.)

(S.D.)

15.07*

12.98*

6.63*

13.34*

13.12*

(14.24)

(14.28)

(10.64)

(15.43)

(13.32)

Mean

Mean

Total
BRI
Mean

15.87*

12.74*

4.09*

12.39*

12.22*

(12.55)

(11.90)

(8.75)

(15.70)

(11.19)

13.47*

12.58*

9.37*

13.95*

13.63*

(16.21)

(17.01)

(12.01)

(15.26)

(15.72)

0.26*

1.19*

1.19

0.19

0.50

(4.56)

(7.07)

(3.75)

(8.07)

(3.00)

0.64*

0.96*

1.56

0.16

0.84

(5.20)

(5.93)

(3.97)

(10.10)

(3.08)

0.13*

1.63*

0.69

0.94

0.13

(3.56)

(8.94)

(3.55)

(3.62)

(2.94)

* indicating sig. t-test difference at p < .01
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Appendix J
Table 6
BRIEF-A Ml Change Scores (Post-Pre) by Condition
n Initiating

Group

Total Malingering 42

CDC Malinger 23

MTVu Malinger 19

Total Control

CDC Control

41

25

MTVu Control 16

Working Planning/
Task Organize Total
Memory Organize Monitor Materials MI

Mean

Mean

Mean

Mean

Mean

Mean

(S.D.)

(S.D.)

(S.D.)

(S.D.)

(S.D.)

(S.D.)

13.12*

20.71 *

17.34*

19.07*

12.37

18.37*

(11.71)

(15.20)

(14.09)

(15.77)

(12.67)

(13.91)

13.22*

20.26*

· 19.22*

21.35*

11.91 *

19.35*

(10.21)

(14.22)

(13.05)

(16.03)

(12.63)

(12.78)

12.32*

19.79*

14.16*

15.53*

12.00* 16.11 *

(13.65)

(17.54)

(15.31)

(15.21)

(13.33) (15.71)

0.26*

0.50*

0.10*

0.48*

0.98*

0.62*

(5.71)

(8. I 0)

(4.15)

(5.14)

(3.39)

(3.62)

0.40*

1.00*

0.28*

1.80*

0.92*

0.40*

(5.29)

(6.06)

(2.25)

(5.93)

(3.19)

(4.37)

1.31 *

0.69*

0.69*

1.31 *

0.81*

0.88*

(6.51)

(10.76)

(6. 19)

(2.89)

(3.75)

(2.25)

* indicating sig. t-test difference from pre-post test mean at p < .01

72

AppendixK
Table 7

DKEFS Scores by Condition
Participant Group
n

Malingering Collapsed

CDC Malingering

MtvU Malingering

Control Collapsed

CDC Control

MtvU Control

42

23

19

41

25

16

1

2

3

4

5

Mean

Mean

Mean

Mean

Mean

(S.D)

(S.D.)

(S.D)

(S.D.)

(S.D)

6.56*

7.66*

7.80*

7.95

9.80*

(4.71)

(3.87)

(4.04)

(3.69)

(2.51)

5.39*

7.48*

7.39*

7.74

10.26

(4.73)

(3.89)

(4.19)

(3.31)

(1.91)

8.11 *

8.05*

8.42*

8.21

9.16

(4.25)

(3.89)

(3.82)

(4. 10)

(3.00)

10.64*

10.69*

11.14*

9.74

11.33*

(2.39)

(2.25)

(2.34)

(2.56)

(1.57)

10.44*

10.28*

10.60*

9.56

11.32

(2.69)

(2.25)

(2.57)

(2.62)

(1.52)

11.06*

11.31

12.06*

10.13

11.56

(1.88)

(2.24)

(1.73)

(2.55)

(1.50)

* indicating sig. t-test difference from controls at p < .01
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Table 8

Digit Span and Reliable Digit Span Scores by Condition

Participant Group

Forward

Backward

Sequencing

N

Mean S.D.

Mean S.D.

MeanS.D.

Malingering Collapsed

42

7.88

3.99

8.22 3.00

8.83* 3.62 8.15* 2.56

CDC Malingering

23

7.13* 1 3.23

7.96 2.99

8.22* 3.61 7.65* 2.67

MTVu Malingering

19

8.84

3.86

8.47 3.01

9.58 3.49 8.79 2.27

Control Collapsed

41

9.62

3.19

9.31

CDC Control

25

10.32* 3.52

9.28 1.97

10.68 2.27 9.68* 1.89

MTVu Control -

16

8.56

9.50 1.83

10.69 1.70 8.88 1.50

1

2.45

Reliable
MeanS.D.

1.91 10.64* 2.03 9.36* 1.75

* indicating sig. t-test difference from controls at p < 0.01,
t indicating sig. !-test difference from published AD/HD norms at p<0.01
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Table 9
TOMMScores by Condition

Participant Group

Learning 1
n

Mean

S.D.

Learning 2
Mean

S.D.

Retention
Mean

S.D.

42

78.34* 1 21.07

85.32* 1 22.33 81.22* 1 25.36

CDC Malingering

23

76.61 *' 19.30

83.83* 1 22.79

81.39* 1 23.32

MTVu Malingering

19

81.47* 1 23.21

87.791

21.74

82.001

27.98

Control Collapsed

41

98.33*

3.12

99.90*

0.43

99.95*

0.31

CDC Control

25

98.72*

2.64

100.00*

0.00

100.00*

0.00

MTVu Control

16

97.75*

3.86

99.88

0.50

99.88

0.50

Malingering Collapsed

* indicating sig. t-test difference from controls at p < 0.01,
t indicating sig. t-test difference from published AD/HD norms at p<0.01
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Table 10
SIM Scores by Condition

n

Total

Psych

Neuro

Arnnestic Low IQ Affect

Mean

Mean.

Mean

Mean

Mean

(S.D)

(S.D.)

(S.D.)

(S.D.)

(S.D.). (S.D.)

Participant Group

Total Malingering

42

CDC Malinger 23

MTVu Malinger 19

Total Control

CDC Control

MTVu Control

41

25

16

Mean

17.13*

1.38*

2.69*

4.03*

3.38*

5.23

(11.71)

(1.80)

(2.47)

(4.33)

(2.87)

(2.22)

19.09*

1.59*

2.82*

4.91 *

3.95

5.09

(11.70)

(1.97)

(2.30)

(4.60)

(3.29)

(1.82)

14.28

1.06

2.50

2.78

2.72

5.22

(11.31)

(1.55)

(2.66)

(3.70)

(2.05)

(2.73)

8.51 *

0.33*

0.90*

1.23*

1.74*

4.31

(2.95)

(0.53)

(0.91)

(1.40)

(1.27)

(1.94)

9.05*

0.41 *

0.73*

1.50*

1.77

4.64

(3.04)

(0.59)

(0.63)

(1.47)

(1.19)

(1.84)

7.75*

0.25

1.06

0.88*

1.56*

4.00

(2.82)

(0.4"4)

(I. 18)

(1.31)

(1.31)

(2.03)

* indicating sig. !-test difference at p < .01

